Optimal screening of heart failure patients: tissue Doppler imaging or plasma NTpro BNP measurement?
Baur
Leo H B
LH
Department of Cardiology, Atrium Medical Centre Parkstad, Henri Dunantstreet 5, 6401CX, Heerlen, The Netherlands. lbr01@atriummc.nl
D015415:Biomarkers / Q000097:blood; D003971:Diastole; D015150:Echocardiography, Doppler; D006333:Heart Failure / Q000097:blood* / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006801:Humans; D008943:Mitral Valve / Q000503:physiopathology; D008955:Models, Cardiovascular; D009038:Motion; D009200:Myocardial Contraction; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D012849:Sinoatrial Node / Q000503:physiopathology; D013318:Stroke Volume; D013997:Time Factors; D016277:Ventricular Function, Left
D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain